Skip to content

13F-HR filed by UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-13, with 25 holding rows worth $41,748,000.

Accession
0001019231-17-000006
Filed
2017-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 25 entries on the cover page, a total value of $41,748,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $41,748,000 with VALUE read as thousands by filing date, 13F file number 028-05714. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Texas Instruments Incorporated882508104COM145,400$13,034,000thousands by filing date
WILLIAMS PARTNERS L P NEW96949L105COM UNIT LTD PAR172,732$6,719,000thousands by filing date
Vanguard FTSE Developed Markets ETF921943858SHS75,430$3,274,000thousands by filing date
Vanguard S&P 500 ETF922908363COM12,446$2,872,000thousands by filing date
Vanguard Mid-Cap Value ETF922908512SHS27,165$2,870,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM524,929$2,588,000thousands by filing date
VWO922042858SHS58,049$2,529,000thousands by filing date
BIO PATH HOLDINGS INC09057N102COM3,830,882$1,379,000thousands by filing date
Vanguard Energy ETF92204A306SHS11,781$1,102,000thousands by filing date
GENERAL MOLY INC COM370373102Common Stock2,922,831$1,096,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM105,465$965,000thousands by filing date
Vanguard Real Estate922908553SHS9,978$829,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM154,301$722,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK35,714$439,000thousands by filing date
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/2372942A107COMMON STOCK62,673$403,000thousands by filing date
COMERICAINC200340107COM4,510$343,000thousands by filing date
INVESCO LTD SHSG491BT108Stock5,900$207,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A5,322$166,000thousands by filing date
FIBROGEN INC31572Q808COM1,133$61,000thousands by filing date
INTERNATIONAL SEAWAYS INC COMY41053102Stock3,000$59,000thousands by filing date
CHIMERA INVESTMENT CORP16934Q208COM NEW3,000$57,000thousands by filing date
ISHARES RUSSELL MID-CAP GROWTH ETF464287481ETF224$25,000thousands by filing date
PORTLAND GEN ELEC CO736508847COM NEW118$5,000thousands by filing date
Boeing Company097023105COM6$2,000thousands by filing date
PepsiCo,Inc.713448108COM20$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001019231-17-000006this filing2017-11-13acceptance time not in the bulk data set